FdaApplication
NDA 018733
Identifiers
- fda_app_no: NDA018733
Properties
| Property | Value |
|---|---|
| applicant_name | SANOFI AVENTIS US LLC |
| application_type | NDA |
| approval_date | 1982-12-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TALWIN NX | NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE | EQ 0.5MG BASE;EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
1 product